FDA
Michigan reports 2 deaths in cyclosporiasis outbreak
Michigan health officials have confirmed two deaths in a widespread cyclosporiasis outbreak linked to iceberg lettuce from Taylor Farms.
Taco Bell sales drop as lettuce parasite outbreak hits US restaurants
Yum Brands reported a decline in Taco Bell same-store sales after a parasite outbreak linked to shredded iceberg lettuce affected several U.S. states.
Midwest Poultry Services recalls 19 million eggs over salmonella risk
Midwest Poultry Services has initiated a voluntary recall of over 1.5 million dozen shell eggs due to potential Salmonella Enteritidis contamination.
Nearly 1.6 million dozen eggs recalled over salmonella risk
Nearly 1.6 million dozen eggs across the American South are being recalled after potential Salmonella Enteritidis contamination was detected.
RFK Jr. says cyclospora outbreak is 'under control
Robert F. Kennedy Jr. defends the government's response to a parasite outbreak linked to lettuce from Mexico amid criticism over changes to surveillance programs.
US cyclosporiasis outbreak linked to Taylor Farms lettuce hits thousands
A record-breaking parasitic outbreak has sickened thousands across the US, leading to widespread recalls of Taylor Farms shredded iceberg lettuce.
CDC, FDA link Taco Bell lettuce supplier to multistate cyclosporiasis outbreak
Federal health officials have traced a multistate outbreak of cyclosporiasis to a single supplier of iceberg lettuce from Mexico serving Taco Bell locations.
Lettuce supplier identified as potential source of cyclosporiasis outbreak
Health officials are investigating shredded iceberg lettuce from Taylor Farms after a parasitic outbreak sickened thousands across 34 states.
Medicare prescriptions for Wegovy jumped after approval for heart disease
New research shows a jump in Wegovy prescriptions as Medicare Part D plans cover the drug for cardiovascular risk reduction, though weight-loss-only use remains prohibited.
Lecanemab for Alzheimer's shows cognitive benefit despite serious risks
Lecanemab has demonstrated a statistically significant ability to reduce cognitive decline in early Alzheimer's patients, despite serious safety risks and high costs.